Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 14:25 ET | Source: Block & Leviton LLP

BREAKING: Compass Diversified (CODI) Shares Down Over 60%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Block & Leviton is investigating Compass Diversified Holdings (NYSE: CODI) for potential securities law violations. Investors should contact the firm.
February 03, 2023 08:00 ET | Source: Helsinn

Helsinn announces publication of new data evaluating impact of NEPA (netupitant/palonosetron) on hospital costs

Helsinn announces publication of new data evaluating impact of NEPA (netupitant/palonosetron) on hospital costs Lugano, Switzerland, February 3, 2023 - Helsinn Group (“Helsinn”), a fully integrated...
January 09, 2023 08:00 ET | Source: Helsinn Healthcare S.A.

Helsinn announces the appointment of Dr Melanie Rolli as Group Chief Executive Officer

Helsinn announces the appointment of Dr Melanie Rolli as Group Chief Executive Officer - Giorgio Calderari appointed Vice Chairman of the Board Lugano, Switzerland, January 9, 2023 - Helsinn Group...
November 29, 2022 08:00 ET | Source: Helsinn Healthcare S.A.

Helsinn announces presentation on CINV trial at European Society for Medical Oncology (ESMO) Asia

Helsinn announces presentation on CINV trial at European Society for Medical Oncology (ESMO) Asia Lugano, Switzerland, November 29, 2022 - Helsinn Group (“Helsinn”), a fully integrated global...
November 28, 2022 06:00 ET | Source: Helsinn Healthcare S.A.

Farma Mondo Group and Helsinn sign exclusive partnership to commercialize AKYNZEO® in the Baltic region

Farma Mondo Group and Helsinn sign exclusive partnership to commercialize AKYNZEO® in the Baltic region CHIASSO, Switzerland and LUGANO, Switzerland – November 28, 2022 – Farma Mondo Group, a...
September 21, 2022 08:34 ET | Source: Helsinn Healthcare S.A.

Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting

Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting Data on chlormethine in both clinical trials and real-world settings will be presentedHelsinn...
August 08, 2022 04:07 ET | Source: Helsinn Healthcare S.A.

Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer

Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer Lugano, Switzerland, August 8, 2022 - Helsinn Group (“Helsinn”), a fully integrated, global...